Atherosclerosis leading to cardiovascular diseases remains a dominant medical problem. In the early stages of this disease, the interaction between circulating monocytes and the endothelium is crucial. Monocytes and macrophages express scavenger receptor A (SR-A), which mediates cell adhesion and subsequently uptake of oxidized low-density lipoproteins (LDL). High iron stores in monocytes or macrophages are known to predispose individuals to atherosclerosis, however the reasons remain poorly understood. We hypothesized that a combination of iron and LDL may induce proatherogenic changes in circulating monocytes. Here, we treated a human monocytic cell line THP-1 with isolated LDL and/or iron. A limited uptake of native LDL, but not iron or oxidized LDL, markedly induced expression of SR-A in these cells. Both SR-AI and SR-AII isoforms were upregulated. The increased SR-A was also seen at the protein level, and LDL treatment increased cellular adhesion. The induction of SR-A by LDL was inhibited by the lysosomotropic thiol WR-1065 and by the chain-breaking lipophilic antioxidant butylated hydroxytoluene (BHT). The fluorescent probe BODIPY C11 exhibited increased lipid peroxidation inside lysosomes after LDL administration. The induction of SR-A by LDL was blocked by two silencing RNAs directed against the nuclear coactivator receptor NCOA4, the cargo receptor necessary for the autophagy of ferritin. These results may point to a new pathogenetic mechanism of early-stage atherosclerosis, in which high iron stores in circulating monocytes, through increased lysosomal lipid peroxidation, may lead to an upregulated expression of SR-A, which makes the cells more adhesive and hence more atherogenic.

Institute of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University Praha 2 Czech Republic

See more in PubMed

Mahmood SS, Levy D, Vasan RS and Wang TJ (2014) The Framingham heart study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 383, 999–1008. PubMed PMC

Halliwell B and Gutteridge JM (2015) Free Radicals in Biology and Medicine. Oxford University Press, New York, NY.

Goldstein JL, Ho YK, Basu SK and Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 76, 333–337. PubMed PMC

Steinberg D (2009) The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 50, S376–S381. PubMed PMC

Plüddemann A, Neyen C and Gordon S (2007) Macrophage scavenger receptors and host‐derived ligands. Methods 43, 207–217. PubMed

Moore KJ and Freeman MW (2006) Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 26, 1702–1711. PubMed

de Winther MP, van Dijk KW, Havekes LM and Hofker MH (2000) Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol 20, 290–297. PubMed

Sullivan JL (1981) Iron and the sex difference in heart disease risk. Lancet 1, 1293–1294. PubMed

Kraml P (2017) The role of iron in the pathogenesis of atherosclerosis. Physiol Res 66, S55–S67. PubMed

Ponka P (1999) Cellular iron metabolism. Kidney Int Suppl 69, S2–S11. PubMed

Vinchi F, Muckenthaler MU, Da Silva MC, Balla G, Balla J and Jeney V (2014) Atherogenesis and iron: from epidemiology to cellular level. Front Pharmacol 5, 94. PubMed PMC

Vinchi F (2021) Non‐transferrin‐bound iron in the spotlight: novel mechanistic insights into the vasculotoxic and atherosclerotic effect of iron. Antioxid Redox Signal 35, 387–414. PubMed PMC

Xu X, Xu XD, Ma MQ, Liang Y, Cai YB, Zhu ZX, Xu T, Zhu L and Ren K (2024) The mechanisms of ferroptosis and its role in atherosclerosis. Biomed Pharmacother 171, 116112. PubMed

Nairz M, Schroll A, Demetz E, Tancevski I, Theurl I and Weiss G (2015) ‘Ride on the ferrous wheel’ – the cycle of iron in macrophages in health and disease. Immunobiology 220, 280–294. PubMed

Sullivan JL and Zacharski LR (2001) Hereditary haemochromatosis and the hypothesis that iron depletion protects against ischemic heart disease. Eur J Clin Invest 31, 375–377. PubMed

Colin S, Chinetti‐Gbaguidi G and Staels B (2014) Macrophage phenotypes in atherosclerosis. Immunol Rev 262, 153–166. PubMed

Piechota M, Banaszewska A, Dudziak J, Slomczynski M and Plewa R (2012) Highly upregulated expression of CD36 and MSR1 in circulating monocytes of patients with acute coronary syndromes. Protein J 31, 511–518. PubMed PMC

Kraml PJ, Klein RL, Huang Y, Nareika A and Lopes‐Virella MF (2005) Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP‐1 mononuclear phagocytes. Metabolism 54, 453–459. PubMed

De Kimpe SJ, Anggârd EE and Carrier MJ (1998) Reactive oxygen species regulate macrophage scavenger receptor type I, but not type II, in the human monocytic cell line THP‐1. Mol Pharmacol 53, 1076–1082. PubMed

Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Seppänen R and Salonen R (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86, 803–811. PubMed

Wen Y and Leake DS (2007) Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ Res 100, 1337–1343. PubMed

Ahmad F and Leake DS (2018) Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: a possible explanation as to why the clinical trials of antioxidants might have failed. Chem Phys Lipids 213, 13–24. PubMed PMC

Čierna M, Buchal R, Leníček M, Shachak A and Pláteník J (2024) Iron‐dependent lysosomal LDL oxidation induces expression of scavenger receptor A in human THP‐1 monocytes. FEBS Open Bio 14, 92–516. PubMed PMC

Markwell MA, Haas SM, Bieber LL and Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87, 206–210. PubMed

Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T and Tada K (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1). Int J Cancer 26, 171–176. PubMed

Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T and Tada K (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42, 1530–1536. PubMed

Chanput W, Mes JJ and Wichers HJ (2014) THP‐1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol 23, 37–45. PubMed

(2002) Basic Cell Culture. 2nd edn. Oxford University Press, Inc., New York, NY.

Dugas TR, Morel DW and Harrison EH (2000) Novel cell culture medium for use in oxidation experiments provides insights into mechanisms of endothelial cell‐mediated oxidation of LDL. In Vitro Cell Dev Biol Anim 36, 571–577. PubMed

Bergmeyer HU (1974) Methods of Enzymatic Analysis. 2nd edn. Academic Press, Inc., New York, NY.

Cohen A, Hertz HS, Mandel J, Paule RC, Schaffer R, Sniegoski LT, Sun T, Welch MJ and White E 5th (1980) Total serum cholesterol by isotope dilution/mass spectrometry: a candidate definitive method. Clin Chem 26, 854–860. PubMed

Teupser D, Thiery J, Walli AK and Seidel D (1996) Determination of LDL‐ and scavenger‐receptor activity in adherent and non‐adherent cultured cells with a new single‐step fluorometric assay. Biochim Biophys Acta 1303, 193–198. PubMed

Zhang X, Wang B, Wang C, Chen L and Xiao Y (2015) Monitoring lipid peroxidation within foam cells by lysosome‐targetable and ratiometric probe. Anal Chem 87, 8292–8300. PubMed

Zima T, Štípek S, Crkovská J and Pláteník J (1995) Measurement of lipid peroxidation product – malondialdehyde – in biological samples by spectrophotometric and HPLC assay (in Czech). Klin Biochem Metab 3, 98–102.

De Aguilar Diaz Leon J and Borges CR (2020) Evaluation of oxidative stress in biological samples using the thiobarbituric acid reactive substances assay. J Vis Exp doi: 10.3791/61122 PubMed DOI PMC

Seo GS, Lee SH, Choi SC, Choi EY, Oh HM, Choi EJ, Park DS, Kim SW, Kim TH, Nah YH PubMed

Buss JL, Neuzil J, Gellert N, Weber C and Ponka P (2003) Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron‐chelating properties. Biochem Pharmacol 65, 161–172. PubMed

Yu Z, Eaton JW and Persson HL (2003) The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron. Redox Rep 8, 347–355. PubMed

Persson HL and Richardson DR (2005) Iron‐binding drugs targeted to lysosomes: a potential strategy to treat inflammatory lung disorders. Expert Opin Investig Drugs 14, 997–1008. PubMed

Yoshimori T, Yamamoto A, Moriyama Y, Futai M and Tashiro Y (1991) Bafilomycin A1, a specific inhibitor of vacuolar‐type H(+)‐ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem 266, 17707–17712. PubMed

Santiago‐García J, Kodama T and Pitas RE (2003) The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J Biol Chem 278, 6942–6946. PubMed

Mancias JD, Wang X, Gygi SP, Harper JW and Kimmelman AC (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509, 105–109. PubMed PMC

Khoo JC, Miller E, McLoughlin P and Steinberg D (1988) Enhanced macrophage uptake of low density lipoprotein after self‐aggregation. Arteriosclerosis 8, 348–358. PubMed

Liu ZD, Khodr HH, Lu SL and Hider RC (2000) Design, synthesis and evaluation of N‐basic substituted 3‐hydroxypyridin‐4‐ones: orally active iron chelators with lysosomotrophic potential. J Pharm Pharmacol 52, 263–272. PubMed

MacDonald ML, Murray IV and Axelsen PH (2007) Mass spectrometric analysis demonstrates that BODIPY 581/591 C11 overestimates and inhibits oxidative lipid damage. Free Radic Biol Med 42, 1392–1397. PubMed

Brown AJ and Jessup W (1999) Oxysterols and atherosclerosis. Atherosclerosis 142, 1–28. PubMed

Iron-dependent lysosomal LDL oxidation induces the expression of scavenger receptor A in human THP-1 monocytes